                         SEQUENCE LISTING

<110>  Coherus Biosciences, Inc.
 
<120>  METHOD OF PRODUCING A RECOMBINANT PROTEIN

<130>  40299-0071WO1

<150>  62/843,270
<151>  2019-05-03

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  110
<212>  PRT
<213>  Artificial

<220>
<223>  Ranibizumab Light Chain

<400>  1

Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Ser Ala Ser Gln Asp Ile Ser Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Val Leu Ile 
        35                  40                  45              


Tyr Phe Thr Ser Ser Leu His Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Ser Thr Val Pro Trp 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
            100                 105                 110 


<210>  2
<211>  158
<212>  PRT
<213>  Artificial

<220>
<223>  Ranibizumab Heavy Chain

<400>  2

Ser Gly Gly Gly Ser Gly Ser Gly Asp Phe Asp Tyr Glu Lys Met Ala 
1               5                   10                  15      


Asn Ala Asn Lys Gly Ala Met Thr Glu Asn Ala Asp Glu Asn Ala Leu 
            20                  25                  30          


Gln Ser Asp Ala Lys Gly Lys Leu Asp Ser Val Ala Thr Asp Tyr Gly 
        35                  40                  45              


Ala Ala Ile Asp Gly Phe Ile Gly Asp Val Ser Gly Leu Ala Asn Gly 
    50                  55                  60                  


Asn Gly Ala Thr Gly Asp Phe Ala Gly Ser Asn Ser Gln Met Ala Gln 
65                  70                  75                  80  


Val Gly Asp Gly Asp Asn Ser Pro Leu Met Asn Asn Phe Arg Gln Tyr 
                85                  90                  95      


Leu Pro Ser Leu Pro Gln Ser Val Glu Cys Arg Pro Phe Val Phe Ser 
            100                 105                 110         


Ala Gly Lys Pro Tyr Glu Phe Ser Ile Asp Cys Asp Lys Ile Asn Leu 
        115                 120                 125             


Phe Arg Gly Val Phe Ala Phe Leu Leu Tyr Val Ala Thr Phe Met Tyr 
    130                 135                 140                 


Val Phe Ser Thr Phe Ala Asn Ile Leu Arg Asn Lys Glu Ser 
145                 150                 155             


